High dose Epirubicin id effective in measurable metastatic prostate cancer: a phase II study of the EORTC genitourinary group

Publication year

1995

Author(s)

Mulder, P.H.M. de

Glabbeke, M. van

Source

European Journal of Cancer, 31A, 10, (1995), pp. 1622-1626

ISSN

DOI

https://doi.org/10.1016/0959-8049(95)00193-M

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/204865

https://hdl.handle.net/2066/204865

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.